1. | | Investment Advisory Fees– Please highlight the statements concerning investment |
| | advisory fees on pages 2, 24 and 34. |
|
| | Response:We revised the disclosure accordingly. |
|
2. | | Free Look– Please clarify on pages 1 and 54 that regardless of state, the insurance |
| | company will not retain any investment gain associated with a contract that is free |
| | looked. Even in states requiring a refund of premium, the company will refund contract |
| | value if greater. |
|
| | Response:We revised the disclosure accordingly. |
|
3. | | Fees and Expenses Tables– Please conform the formatting of the fee and expense tables |
| | and the related footnotes. |
|
| | Response:We added a box to and around each table and revised the formatting and |
| | layout to improve the presentation of information, with the footnotes appearing at the end |
| | of each table. |
4. | | Example– Please confirm that the annual contract administrative charge is reflected in |
| | the example. |
|
| | Response:The annual contract administrative charge is not reflected in the example |
| | because no contracts have been issued to date. We revised the disclosure accordingly. |
|
5. | | Legal Proceedings– We note that the disclosure about material pending legal proceedings |
| | does not address the actions against the company in New Hampshire and New York. |
| | Please advise. |
|
| | Response:These matters concerned affiliates of the company having reached a |
| | settlement with each of the New Hampshire Bureau of Securities Regulation and the New |
| | York Attorney General on October 10, 2006, which the company disclosed on or about |
| | October 11, 2006. The company thereafter updated this disclosure in April of this year |
| | and intends to further consider updating the material pending legal proceedings |
| | disclosure this coming April. |
|
6. | | Master-Feeder Funds– Please confirm that the company delivers the prospectuses for |
| | both the master fund and the feeder funds with funds offered in a master-feeder structure |
| | where the master fund has not signed the registration statement of a feeder fund. |
|
| | Response:We confirm that the company delivers the prospectuses for both the master |
| | fund and feeder funds in this case. |
|
7. | | Redemption Fees– Please disclose whether any of the underlying portfolios impose a |
| | redemption fee, and if not, then so state in the fee tables. |
|
| | Response:No trust or fund underlying the contract currently charges a redemption fee, |
| | which footnote one indicates to the table of total annual trust or fund operating expenses. |
|
8. | | Defined Term– Please provide a definition for the term “enhanced death benefit” or |
| | reconcile its use. |
|
| | Response:We revised the disclosure to remove reference to the term “enhanced death |
| | benefit” and instead refer to a particular death benefit option package, as appropriate. |
|
9. | | Market Value Adjustment– Please confirm whether the market value adjustment |
| | associated with Fixed Account II is registered. |
|
| | Response:The market value adjustment feature is registered under the Securities Act of |
| | 1933 – File No. 333-133156. |
10. | | State Variations– Please remove the statement indicating that the contract, any |
| | endorsements and riders are the controlling documents over the prospectus. |
|
| | Response:We revised the sentence to clarify that the contract, any endorsements and |
| | riders contain more detailed information about the features, benefits and costs since the |
| | prospectus only provides a general description. |
|
11. | | ING LifePay Plus Minimum Guaranteed Withdrawal Benefit Rider– Please correct the |
| | misspelled word in the first sentence of the “No Cancellation” paragraph. |
|
| | Response:We made the correction. |
|
12. | | Free Look– Please revise the disclosure to reflect that contract value “will” be allocated |
| | to the specially designated subaccount, as opposed to “may,” in states requiring return of |
| | premium. |
|
| | Response:We revised the disclosure accordingly. |
|
13. | | Annuity Options and Expense Risk Charge– Please provide justification for deduction |
| | of the Mortality and Expense Risk Charge for a nonlifetime annuity payment option. |
|
| | Response:The justification is the expense risk associated with administering variable |
| | annuity payments. The contract provides for deduction of the charge at the same rate |
| | even when there are no mortality risks to assume with a nonlifetime annuity payment |
| | option. Within “The Annuity Options – Charges Deducted,” we added clarifying |
| | disclosure distinguishing the mortality and expense risks with a lifetime annuity option |
| | from the expense risks with a nonlifetime annuity payment option whenever variable |
| | annuity payments are selected. |
|
14. | | Voting Rights– Please indicate that the effect with echo voting is a small number of |
| | instructions may determine the outcome of the vote. |
|
| | Response:We revised the disclosure accordingly. |
|
15. | | Statement of Additional Information – Performance Information– Please revise and/or |
| | remove the references to the Max 7 Enhanced Death Benefit and the MGIB optional |
| | benefit rider. |
|
| | Response:We revised the disclosure to reflect selection of the Option Package III death |
| | benefit and the ING Joint LifePay Plus MGWB optional benefit rider. |
|
16. | | Tandy Comment– Please provide Tandy representations with your response letter. |
|
| | Response:The registrant acknowledges that (i) we are responsible for the adequacy and |
| | accuracy of the disclosure in the filing, (ii) Staff comments or changes to disclosure in |